Strategies that improve skeletal muscle metabolic function and insulin sensitivity could therefore have a major impact on the obesity induced development of insulin resistance and diabetes and reduce health care costs and improve quality of life. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.